PDE5A and breast carcinoma: As shown in Figure 4I (lower panel), PDE5 overexpression in MEFs also stimulated breast cancer cell motility and sildenafil treatment of CAFs reversed these effects, further highlighting the potential of PDE5 to influence stromal fibroblast activation.